Koers Delta 9 Cannabis Inc Toronto S.E.
Aandelen
CA2477541049
Farmaceutische producten
Omzet 2024 * | 75,8 mln. 55,17 mln. 51,06 mln. | Omzet 2025 * | 86,6 mln. 63,03 mln. 58,34 mln. | Marktkapitalisatie | 6,04 mln. 4,4 mln. 4,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,08 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,07 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,89% |
Recentste transcriptie over Delta 9 Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07-09-18 |
Nitin Kaushal
CHM | Chairman | 58 | 31-10-17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,69% | 723 mld. | |
+34,28% | 595 mld. | |
-4,49% | 369 mld. | |
+20,24% | 332 mld. | |
+2,12% | 282 mld. | |
+17,02% | 244 mld. | |
+9,31% | 208 mld. | |
-5,07% | 205 mld. | |
-0,35% | 168 mld. |